United States · FDA National Drug Code directory
HYLENEX Recombinant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 18657-117_37c02d08-e964-4065-ba96-69fe8eed5c2e
- Product NDC
- 18657-117
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Hyaluronidase
- Labeler
- Antares Pharma, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20051202
- Source listing expiry
- 20261231
Source-listed ingredients
- HYALURONIDASE (HUMAN RECOMBINANT) — 150 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01) · 18657-117-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →